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 The importance of body weight of patients on admission in the management of diabetes was studied using 
Data from the University of Ilorin Teaching Hospital on the management of diabetes. Weight was partitioned into three 
groups: underweight, normal weight and overweight. Three models were used for comparison: a model that used 
weight of diabetes patient as a covariate, a second that used both weight and admitting blood sugar reading of 
diabetes patients as covariates and the third separate models for each of the three weight groups of diabetes patient 
as covariate. 
Results showed that the latter model performed better than the earlier two models that were considered on this study 
based on the adjusted R2. Also our finding revealed that the minimum expected days to bring down the blood sugar 
level to threshold value are: 8 days for underweight, 12 days for normal weight and 27 days for overweight. 
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1. INTRODUCTION:    
 
 
 Obesity is a nutritional disorder that is 
characterized by excessive accumulation of fat in any or 
all of the subcutanenus tissues, omentum and viscera 
and muscles. Obesity in diabetes is common in the 
developed world because of gross overeating and eating 
of high fat and refined carbohydrate foods. Its high 
prevalence in developing countries is associated with 
poverty, ignorance about good nutrition and ideal body 
weight and consumption of excessive amount of 
carbohydrate. See Kwawukume and Emuveyan(2002). 
Body mass index (BMI) is used to measure obesity and 
because it is caused as described above it may be a 
factor in developing diabetes. It is the most appropriate 
measure for assessing weight change since weight 
readily changes more rapidly than height. Therefore in 
an attempt to determine how an erstwhile high blood 
sugar level can be brought down to the threshold value, 
this work introduces BMI into the follow-up study of in- 
patient diabetes patients as a covariate. 
In this paper, the methodology of analysis is presented 
in section two. In section three we use the re-analyzed 
of UITH (University of Ilorin Teaching Hospital) data and 
end this paper with a conclusion in section four.     
  
2. METHODOLOGY: 
Let ijty  be the response observed on the 
thi  subject in 
group j at time t, i= 1,2,…, jn ,  j = 1,…,J and t = 
1,2,…, iT . Let ~X ′= .),,...,( 1 nnXX j







vector of covariates. Using the model which is an 
extension of that used by Abidoye and Jolayemi (2005), 
(2006) and Jolayemi and Abidoye (2005) that introduced 
some covariates into the system of equations the 







11 θθ tfXfyE ijt +=  
where 1f  represents the function for the covariate and 
2f  the function representing the model for the repeated 
observations. 1f  and 2f  may be linear or non-linear, 
although 1f  is usually linear, see example from Draper 
& Smith (1966). The Expected Mean (EM) or Newton –








1 θθθ = as described explicitly in Abidoye and 
Jolayemi (2006) using Least Square Estimation 
Methodology. Further explanation on curve fitting can 
also be found in McCullagh & Nelder (1989), Jolayemi 
(1995), Oyejola & Jolayemi(1997). 
The first model to be considered in this study is fully 
discussed in Abidoye and Jolayemi (2006), where the 
covariate is admitting blood sugar reading. In this 







11 θθ tfXfyE ijt +=  
Next let 1X  represent weight and  2X  initial blood 
sugar reading on admission. 
For the diabetes data, 
)3.2(......................).....()(),(),( 2211222111 ⋅⋅ −+−=+ XXXXXfXf jj λθθθ  
)4.2.......(......................................................),( 22 jtjetf




  391 
A. O. Abidoye, Department of Statistics, University of Ilorin, Ilorin, Nigeria. 
E. T. Jolayemi, Department of Statistics, University of Ilorin, Ilorin, Nigeria. 
 
Where j = 1, 2, 3 represents the three BMI groups. 
ii andXX 21 represent weight and admitting blood sugar 
readings respectively, ∑=⋅
j
ji nXX /11  and 
∑=⋅
j
ji nXX /22 and jα  and jtβ  represents 
parameter estimate in the model.  
Obviously, because of the repeated nature of ijty  , 
0)cov( , ≠′′′ tjiijt yy to ensure errors.  
Indeed, jjtiit yy ρσ
2
)(, )cov( =+  is assumed and this 
was recognized and used in the analysis. If desirable, it 
is not difficult to partition the data according to the 
severity level of diabetes of the patient as adopted by 
Abidoye and Jolayemi (2006). 
 
 
3. RE- ANALYSIS OF DIABETES DATA: 
The body mass index was classified into three groups: 
underweight is measure 19.8 2/ mkg  and below 
(group1), normal weight is measure between 19.9 -
29.9 2/ mkg (group2) and overweight is measure above 
30 2/ mkg (group3) as reported by Kwawukume and 
Emuveyan(2002).    





βαθ ++−=   
where ⋅1X  is as defined earlier. 
Table 3.1 is the ANOVA table arising from equation (3.1) 
providing an adjusted 2R =0.632, which is an 
improvement of above 10% in explained variability 
compared to the nonlinear model that does not consider 
any covariate. The estimates of the parameters are 
=θ̂ 0.014± 0.0021, =α̂ 2.432 ± 0.036 and β̂ =-0.040 
± 0.0021 each of which is significant at 5% level.
 
Table 3.1: ANOVA table for equation (3.1) for the diabetes clinical management 
Source                                D.F              SS                                   MS                    F                                
 
Regression                            3           20345.63                         6781.88               607.15 
Parameter estimate: 
θ                                            1           9748.95                          9748.95               872.77 
α                                           1           6358.01                          6358.01               569.20 
β                                           1           4238.67                          4238.67               379.47 
Error                                   1063     11870.49                         11.17    
                                                                                                                                             
Total                                    1066     32216.12 
 






where ⋅1X and ⋅2X  are as defined earlier. 
 
 
Table 3.2 is the ANOVA table for equation (3.2) 
providing an adjusted 2R = 0.672, which is an 









nonlinear model that does not consider the included 
covariates. The estimates of the parameters are 
=θ̂ 0.010± 0.0001,  λ̂  = 0.014± 0.0022, =α̂ 2.10 
± 0.000003 and β̂ =-0.021 ± 0.00013 
each of which is significant at 5% level. 
 
Table 3.2: ANOVA table for equation (3.2) for the diabetes clinical management. 
Source                                D.F              SS                                   MS                    F                                
Regression                           4           21635.22                         5408.81               543.05 
Parameter estimate: 
θ                                            1           7239.62                          7239.62               726.87 
λ                                           1           6841.04                          6841.04               686.85  
α                                           1           4251.24                          4251.24              426.83 
β                                           1           3303.32                          3303.32             331.66 
Error                                   1062     10580.90                         9.96    
                                                                                                                                             
Total                                    1066     32216.12 
 
Next, a further possible improvement for the re-analysis 
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arising from the gains observed in table 3.3 where j= 
1,2,3 represent the three BMI groups using initial blood 
sugar as the covariate and ⋅2X  is as defined earlier. The 
goodness-of-fit is assessed in table 3.3 with an adjusted 
2R = 0.705. The estimates of the parameters are  λ̂  = 
0.032± 0.0004, =1α̂ 2.40 ± 0.0024, 2α̂ =2.11±  0.001, 
3α̂ = 2.04 ± 0.006, 1β̂ =-0.02 ± 0.00017, 2β̂  =-0.010±  
0.0028, and  3β̂ =-0.04± 0.00031. 
 
Table 3.3: ANOVA table for equation (3.3) using initial blood sugar as the covariate. 
Source                                D.F              SS                                   MS                    F                                
Regression                           7           22721.84                         3245.98               361.87 
Parameter estimate: 
λ                                           1           9824.06                          9824.06              1095.21 
α                                           3           7569.78                          2523.26              281.30 
β                                           3           5328.00                          1776.00             197.996 
Error                                   1059        9494.28                           8.97    
                                                                                                                                             
Total                                    1066     32216.12 
 




jjeXXyE βαθ +⋅ +−=
 
Table (3.4) is the ANOVA table for equation (3.4) 
providing an adjusted 2R = 0.764 to assess goodness – 
of –fit. (This provided above 26% gain in explained 
variability). The estimates of the parameters are 1̂θ  = 
0.51± 0.001, =1α̂ 2.64 ± 0.05,  2θ̂  = 0.21±  0.007 
2α̂ =2.49±  0.03, 3α̂ = 2.04 ± 0.006, 1β̂ =-0.06 ± 0.005, 
2β̂  =-0.02±  0.0008,   
3β̂ =-0.014± 0.0002 and 3̂θ =0.19 ±  0.004
 
 
Table3.4: ANOVA table for equation (3.4) with weight as covariate. 
Source                                D.F              SS                                   MS                    F                                
Regression                          9           24601.64                         2733.52               379.66 
Parameter estimate: 
 θ                                          3           10201.41                       3400.47              472.29 
α                                          3           8691.62                          2897.21             402.39 
β                                          3           5708.61                          1902.87             264.29 
Error                                  1057        7614.48                           7.20    
                                                                                                                                             





 Results show that the improvement in bringing 
down the blood sugar level depends on the weight of the 
diabetes patients as well as the reading of the admitting 
blood sugar level. This was shown clearly in equation 
(3.4) and its goodness-of-fit. In this regard, the data on 
diabetes should be analyzed within each BMI group of 
diabetes patients including the initial blood sugar 
reading as a covariate. The re-analysis shows that the 
expected minimum number of days for the management 
to bring down the blood sugar level to an acceptable 
value can be evaluated using the estimated values of 
the parameters in equation (3.4). Indeed, the expected 
minimum number of days for management to bring down 
the blood sugar level to acceptable value 5.6 
millimoles/litter found to be 8days for underweight, 
12days for normal weight and 27days for overweight. 
Consequently, the expected cost of management each 






Abidoye, A. O and Jolayemi, E. T., 2006. Nonlinear 
 Modelling of Repeated Measures: Clinical 
 Management of Diabetes. Journal of Nigerian 
 Statistical Association. 18, page 71-76. 
 
Abidoye, A.O and Jolayemi, E. T., 2005. Model for 
 Clinical Management of Adolescent and Non 
 Adolescent diabetes patients: Nigerian Journal 
 of Pure and Applied Science. 20, page 1811-
 1815. 
 
Draper, N. R and Smith, H., 1966. Applied Regression 
 Analysis. John Wiley & Sons, New York. 
 
Jolayemi, E. T and Abidoye, A. O., 2005. On the Model 
 for the Clinical Management of Diabetes: 
 Nigerian Journal of Pure and Applied Science.. 
 20, page1879- 1883. 
 
Jolayemi, E. T., 1995. A Monte Carlo study of the 
 methods of Estimating parameters of the logistic 
     MODEL FOR CLINICAL MANAGEMENT USING BODY MASS INDEX OF DIABETES PATIENTS                      393
 
 model. Nigerian Journal of Pure and Applied 
 Science 10, 91-103 
 
Kwawukume, E.Y and Emuveyan, E. E., 2002. 
 Comprehensive Obstetrics in the Tropics. 
 Asante and Hittscher Printing Press Limited. 
 
Oyejola, B. A and Jolayemi, E. T., 1997. A comparison 
 of some models for studying relationships of the 
 sigmoid form. Nigerian Journal of Pure and 
 Applied Science 31:193-198. 
 
Mccullagh, P. AND Nelder, J. A., 1989. Generalized 



























































     394                                      A. O. ABIDOYE AND E. T. JOLAYEMI 
